News | Coronavirus (COVID-19) | March 31, 2020

SNMMI Launches COVID-19 Resource Center

The society's COVID-19 Resource Center will be updated regularly and expanded with new information and resources

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

March 31, 2020 — In a letter to its members, Society of Nuclear Medicine and Molecular Imaging (SNMMI) President Vasken Dilsizian, M.D., announced the development of a COVID-19 Resource Center to consolidate information and resources to help members navigate through these difficult times. 

In the letter, Dilsizian outlines some of the current challenges, which include:

  • Nuclear medicine physicians and technologists are being called upon to step outside of nuclear medicine to help with work related to COVID, sometimes with inadequate protection. They are being challenged to conduct essential studies while minimizing COVID exposure to themselves, patients and other personnel.
  • Nuclear medicine researchers are facing mandatory closure of labs, forcing discontinuation of research.
  • Nuclear medicine pharmacists are challenged to ensure that all needed clinical drugs are produced, with concern about the isotope pipeline.
  • Educators are being forced to transition, quickly, to virtual learning with no preparation and limited resources.
  • Residents and students are trying to understand how to continue their path forward and how they can continue their education with such uncertainty.
  • Nuclear medicine professionals are in some cases facing furloughs or layoffs.

The new a COVID-19 Resource Center will include the following, and will be updated regularly and expanded with new information and resources:

  • Information specific to nuclear medicine, including advice on ventilation/perfusion studies and updates on radioisotope supply, as well as useful articles from The Journal of Nuclear Medicine.
  • Government resources on COVID from nine different agencies
  • Other resources, such as the American Medical Association and COVID data websites
  • Training and certification resources, with advice from nuclear medicine–related boards and associations
  • Current status of SNMMI’s Annual Meeting in June.

"We are here to help. We are regularly polling members to find out what challenges you are facing and how SNMMI can support you. Please contact us with any issues or questions at [email protected], and we will do everything within our power to assist," stressed Dilsizian in his written statement. "We remain deeply grateful for your support. I hope you and your loved ones are healthy and safe. This is a challenging time, but nuclear medicine professionals are strong and resilient, and I know that we will get through this together — united — as THE nuclear medicine community."

For more information: www.snmmi.org

 

Related Content

Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

56-Year-Old Woman With Benign Hemangioma: Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma.

News | Magnetic Resonance Imaging (MRI) | October 16, 2020
October 16, 2020 — 
Carestream Health will offer insights on technology, innovative new products and research in medical imaging through a new webinar series titled Carestream Talks. #RSNA20
News | Radiology Education | October 14, 2020
October 14, 2020 — Carestrea
The use of CT and X-ray in the assessment and treatment plan for President Trump underscores the critical role that medical imaging must play in the fight against COVID-19

A COVID-19 chest CT heat map from RADlogics

News | Artificial Intelligence | October 13, 2020
October 13, 2020 — Given recent high-profile cases of...